)
Visual
earnings real time
Isofol Medical (ISOFOL) investor relations material
Isofol Medical ABGSC Investor Days summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.ABGSC Investor Days summary4 Dec, 2025
Key strategic pillars and market opportunity
Focus on high unmet medical need in oncology, targeting cancers with poor response rates to current therapies.
Arfolitixorin, a next-generation direct-acting folate, is designed to enhance efficacy of 5-FU-based chemotherapy.
Large market opportunity, with global colorectal cancer market projected to exceed $17 billion by 2030.
Blockbuster sales potential in the US for metastatic colorectal cancer, with additional upside in other regions and indications.
Strong partner network and expert advisory board support clinical and commercial execution.
Clinical development and scientific evidence
Ongoing phase Ib/II trial in metastatic colorectal cancer, with safety and tolerability of new dosing regimen validated.
Arfolitixorin demonstrated higher MTHF levels in tumors and a dose-response relationship, supporting improved efficacy over leucovorin.
Phase III data showed arfolitixorin matched standard of care efficacy despite suboptimal dosing; new regimen aims to enhance outcomes.
Collaboration with Charité, a leading hospital, and global experts ensures robust clinical development.
Solid evidence platform and CMC readiness de-risk the clinical program and facilitate market adoption.
Forward-looking statements and ambition
Management expresses intent to improve cancer treatment outcomes and create value for patients, healthcare providers, and stakeholders.
Forward-looking statements highlight risks and uncertainties but emphasize commitment to ongoing development.
Aim to impact millions of patients by enabling better treatment responses and improved prognosis.
How does new dosing regimen address Phase III issues?
Prioritize next markets or indications for arfolitixorin
What MTHF level target for optimal efficacy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Isofol Medical earnings date
Q4 202518 Feb, 2026
Next Isofol Medical earnings date
Q4 202518 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Isofol Medical is a biopharmaceutical company developing oncology treatments. It focuses on improving existing chemotherapy-based therapies with novel formulations to enhance effectiveness and reduce side effects. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage